The search for meaning in monoclonal protein - Is it multiple myeloma or monoclonal gammopathy of undetermined significance?

Authors
Citation
Ml. Brigden, The search for meaning in monoclonal protein - Is it multiple myeloma or monoclonal gammopathy of undetermined significance?, POSTGR MED, 106(2), 1999, pp. 135-142
Citations number
26
Categorie Soggetti
General & Internal Medicine
Journal title
POSTGRADUATE MEDICINE
ISSN journal
00325481 → ACNP
Volume
106
Issue
2
Year of publication
1999
Pages
135 - 142
Database
ISI
SICI code
0032-5481(199908)106:2<135:TSFMIM>2.0.ZU;2-3
Abstract
Multiple myeloma and MGUS are the two most common causes of monoclonal prot ein in serum or urine. The usually accepted diagnostic triad for multiple m yeloma consists of a significant paraprotein in the serum or urine, more th an 10% to 15% plasma cells in bone marrow, and the presence of bony lesions . Patients who meet the first two criteria but have no bony lesions, cytope nias, renal failure, or hypercalcemia may have smoldering myeloma, which of ten can be observed for a period of time before therapy is required. MGUS is characterized by a serum IgG monoclonal protein less than 3.5 g/dL or IgA paraprotein less than 2 g/dL, with no or only a small amount of prot ein in urine (Bence Jones protein <1 g/24 hr). Less than 10% plasma cells a re present in bone marrow, and patients have no lytic bony lesions, anemia, hypercalcemia, or renal insufficiency. Another important criterion for MGU S is stability of the monoclonal protein over time. Nonetheless, during lon g-term followup, an associated malignant process develops in about 30% of M GUS patients. Since none of the features defining MGUS is uniformly helpful in predicting the risk for malignant disease, patients should be followed up on a regular basis indefinitely.